|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.13 USD | +1.71% |
|
+2.81% | -2.19% |
| 26/01 | Sector Update: Health Care Stocks Mixed Premarket Monday | MT |
| 26/01 | Biomarin Pharmaceutical Inc. Announces $850 Million of Senior Unsecured Notes Due 2034 | CI |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Development and Commercialization of Innovative Therapies | 186.05Cr | 184.63Cr | 209.6Cr | 241.92Cr | 285.39Cr | |||||
Total Assets | 584.8Cr | 600.33Cr | 637.51Cr | 684.16Cr | 698.89Cr | |||||
Interest Expense | -2.93Cr | -1.53Cr | -1.6Cr | -1.73Cr | -1.27Cr | |||||
Income Tax Expense | -90Cr | -1.13Cr | 80.15L | 2.09Cr | 11Cr | |||||
CAPEX | -14Cr | -12Cr | -13Cr | -9.67Cr | -8.54Cr | |||||
EBT | -4.23Cr | -7.54Cr | 15Cr | 19Cr | 54Cr | |||||
D&A | 11Cr | 11Cr | 10Cr | 10Cr | 9.64Cr | |||||
Operating Income | -3.68Cr | -8.23Cr | 15Cr | 16Cr | 48Cr | |||||
Net Income | 86Cr | -6.41Cr | 14Cr | 17Cr | 43Cr |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 91Cr | 66Cr | 68Cr | 77Cr | 92Cr | |||||
Total Assets | 77Cr | 76Cr | 79Cr | 79Cr | 76Cr | |||||
Total Assets | 30Cr | 30Cr | 31Cr | 31Cr | 31Cr | |||||
Europe | 52Cr | 56Cr | 65Cr | 67Cr | 83Cr | |||||
Total Assets | - | - | - | - | - | |||||
Rest of World | 22Cr | 25Cr | 31Cr | 47Cr | 49Cr | |||||
Total Assets | 1.77Cr | 1.33Cr | 1.86Cr | 1.71Cr | 1.36Cr | |||||
Latin America | 21Cr | 19Cr | 27Cr | 33Cr | 38Cr | |||||
Unallocated | - | 12Cr | 13Cr | 13Cr | 18Cr |
- Stock Market
- Equities
- BMRN Stock
- Financials BioMarin Pharmaceutical Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition